Alberta Health and Wellness Minister Ron Liepert announced details of the first phase of the province's major new pharmaceutical strategy on December 8.
Pharmacists in London, England will receive authorization next year to supply women with the oral contraceptive pill over-the-counter-without the need for a doctor's prescription-as part of a new pilot project.
GlaxoSmithKline's Volibris is a new endothelin receptor antagonist for the treatment of idiopathic (primary) pulmonary arterial hypertension, as well as PAH associated with connective tissue disease.
Ontario Public Drug Programs is asking pharmacists to be part of a pilot project for the next phase of MedsCheck, which is expected to begin in January 2009.
Calgary Co-operative Association Limited has made its first foray into the home health care market with the recent purchase of Home Health Care and Medical Supply Centre.
